|
SBTX | Ars Pharmaceuticals, Inc. |
|
|
SBTX | Ars Pharmaceuticals, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.61 |
| Leverage | 7.64% |
| Market Cap | $ 329.3m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -48.9m |
| Margin | -352.14% |